CHAIR
:
SPEAKER
(S):
Edgar (Chip) Cale, Esq, Vice President & Associate General Counsel, World Wide Business Development Transactions , GlaxoSmithKline
Morgan Conn, Manager, Business Development , PTC Therapeutics, Inc
Elan Ezickson, JD, Chief Business Officer , AVEO Pharmaceuticals, Inc
Anton Gueth, Managing Director, Burrill & Company: Venture Capital, Merchant Banking, Media , Burrill & Company
Adriann Sax, Executive Vice President, Business Development &. Strategic Planning , King Pharmaceuticals, Inc
Description
"Strategic alliances, collaborations and key intellectual property license arrangements play a key role in the ever-evolving life sciences industry. Recent years have seen a sharp increase in global biotech and pharmaceutical companies partnering
with smaller companies to collaborate much earlier in the development process. Highlighting recent high-profile earlystage collaborations and analyzing notable alliance successes
and failures, this panel presentation will suggest proactive strategies and tactics to improve the odds of success."
Objective1: Prepare for the main risks and challenges presented by emerging markets.
Objective2: Understand actionable best practices and insights to help build organizational capabilities and improve deal processes.
Objective3: Learn from other industries what contributes to success and failure in emerging markets transactions.